Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild-type p53.

about

The animal-dependent risk factors in canine osteosarcomas.Comparative oncology approach to drug repurposing in osteosarcoma.

P2860

Q38596972-56D79991-534D-4EAB-BA90-B0490CADA094 Q52631134-721BE9A0-EA2F-43EE-87FD-5192583DF104

P2860

Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild-type p53.

Item

http://www.wikidata.org/entity/Q38762792

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Enrofloxacin enhances the effe ...... with mutant and wild-type p53.

@en

type

Item

label

Enrofloxacin enhances the effe ...... with mutant and wild-type p53.

@en

prefLabel

Enrofloxacin enhances the effe ...... with mutant and wild-type p53.

@en

P1476

Enrofloxacin enhances the effe ...... with mutant and wild-type p53

@en

P2093

D York

http://www.w3.org/2001/XMLSchema#string

K D Watson

http://www.w3.org/2001/XMLSchema#string

R B Rebhun

http://www.w3.org/2001/XMLSchema#string

S S Withers

http://www.w3.org/2001/XMLSchema#string

P2860

Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line

Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.

The effects of enrofloxacin on canine tendon cells and chondrocytes proliferation in vitro.

TP53 mutations in human cancers: origins, consequences, and clinical use

Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing.

Ciprofloxacin as a potential radio-sensitizer to tumor cells and a radio-protectant for normal cells: differential effects on γ-H2AX formation, p53 phosphorylation, Bcl-2 production, and cell death

Genomic instability and telomere fusion of canine osteosarcoma cells.

Fluoroquinolone-mediated inhibition of cell growth, S-G2/M cell cycle arrest, and apoptosis in canine osteosarcoma cell lines.

Targeting the transposase domain of the DNA repair component Metnase to enhance chemotherapy

The effect of Zhangfei/CREBZF on cell growth, differentiation, apoptosis, migration, and the unfolded protein response in several canine osteosarcoma cell lines.

P304

1087-1100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/VCO.12250

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kyoung-Won Seo

P577

2016-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27333821

http://www.w3.org/2001/XMLSchema#string

P932

5182190

http://www.w3.org/2001/XMLSchema#string

Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild-type p53.

about

P2860

P2860

Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild-type p53.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932